The novel treatment of the medication represents a exciting breakthrough in the management of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets two pathways – GLP-1 and GIP – providing https://tirzepatidepeptide141612.blogzag.com/85455231/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment